Intellect Neurosciences, Inc. Issues Letter to Shareholders
19 mars 2015 07h30 HE
|
Intellect Neurosciences, Inc.
NEW YORK, March 19, 2015 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPNK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic and...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
24 sept. 2014 08h00 HE
|
Intellect Neurosciences, Inc.
NEW YORK, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPNK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
13 août 2014 08h00 HE
|
Intellect Neurosciences, Inc.
NEW YORK, Aug. 13, 2014 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
31 juil. 2014 08h00 HE
|
Intellect Neurosciences, Inc.
NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPNK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents...
Intellect Neurosciences Obtains Patent Allowance From the United States Patent and Trademark Office in Relation to Its TOC-1 Monoclonal Antibody Selective for Pre-Fibrillar Tau Aggregates
14 nov. 2013 14h15 HE
|
Intellect Neurosciences, Inc.
NEW YORK, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic and...
Intellect Neurosciences Retains Chain Pharmaceuticals LLC
30 juil. 2013 11h30 HE
|
Intellect Neurosciences, Inc.
NEW YORK, July 30, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS) announced today it has retained Chain Pharmaceuticals LLC as a consultant to assist the company in managing its...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
20 juin 2013 09h25 HE
|
Intellect Neurosciences, Inc.
NEW YORK, June 20, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of treatments for the prevention and...
Intellect Neurosciences Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value
18 juin 2013 11h31 HE
|
Intellect Neurosciences, Inc.
NEW YORK, June 18, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of treatments for the prevention and...
Intellect Neurosciences Issues Letter to Shareholders
29 mars 2013 09h35 HE
|
Intellect Neurosciences, Inc.
NEW YORK, March 29, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of treatments for the prevention and...
Intellect Neurosciences to Present at Bio-Europe Spring Conference in Barcelona
28 févr. 2013 09h35 HE
|
Intellect Neurosciences, Inc.
NEW YORK, Feb. 28, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS) announces Dr. Daniel G. Chain, Chairman and CEO, will present at the Bio-Europe Spring Conference March 11-13,...